Collegium Pharmaceutical (COLL) Other Accumulated Expenses (2014 - 2025)

Collegium Pharmaceutical's Other Accumulated Expenses history runs 12 years deep, the most recent figure standing at $6.4 million for Q3 2025.

• In Q3 2025, Other Accumulated Expenses rose 31.42% year-over-year to $6.4 million; the TTM figure through Sep 2025 stood at $6.4 million (up 31.42% YoY), while the FY2024 annual figure was $4.8 million, up 32.17% from the prior year.
• Other Accumulated Expenses was $6.4 million for Q3 2025 at Collegium Pharmaceutical, up from $4.3 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $6.4 million in Q3 2025 to a low of $578000.0 in Q1 2021.
• Historically, Other Accumulated Expenses has averaged $3.4 million across 5 years, with a median of $3.4 million in 2022.
• The sharpest annual moves came in 2021 and 2022: Other Accumulated Expenses slumped 63.74% in 2021, then jumped 816.61% in 2022.
• A 5-year view of Other Accumulated Expenses shows it stood at $2.8 million in 2021, then climbed by 21.28% to $3.4 million in 2022, then advanced by 4.41% to $3.6 million in 2023, then jumped by 32.17% to $4.8 million in 2024, then surged by 33.98% to $6.4 million in 2025.
• The last three Other Accumulated Expenses figures came in at $6.4 million (Q3 2025), $4.3 million (Q2 2025), and $4.8 million (Q1 2025), per Business Quant data.